-SEC Filing
GENFIT Announces Publication In The Journal Of Hepatology On The Accurate Performance Of NIS2+ As A Screening Tool For The Enrollment Of Patients In MASH Clinical Trials
The paper published in Journal of Hepatology demonstrates that NIS2+™ technology could significantly reduce liver biopsy failure rate and maximizes accuracy of patient selection for MASH1 clinical trialsGrowing